The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Activation Status of Human Microglia Is Dependent on Lesion Formation Stage and Remyelination in Multiple Sclerosis
Open accessAbstract
Similar to macrophages, microglia adopt diverse activation states and contribute to repair and tissue damage in multiple sclerosis. Using reverse transcription-quantitative polymerase chain reaction and immunohistochemistry, we show that in vitro M1-polarized (proinflammatory) human adult microglia express the distinctive markers CD74, CD40, CD86, and CCR7, whereas M2 (anti-inflammatory) microglia express mannose receptor and the anti-inflammatory cytokine CCL22. The expression of these markers was assessed in clusters of activated microglia in normal-appearing white matter (preactive lesions) and areas of remyelination, representing reparative multiple sclerosis lesions. We show that activated microglia in preactive and remyelinating lesions express CD74, CD40, CD86, and the M2 markers CCL22 and CD209, but not mannose receptor. To examine whether this intermediate microglia profile is static or dynamic and thus susceptible to changes in the microenvironment, we polarized microglia into M1 or M2 phenotype in vitro and then subsequently treated them with the opposing polarization regimen. These studies revealed that expression of CD40, CXCL10, and mannose receptor is dynamic and that microglia, like macrophages, can switch between M1 and M2 phenotypic profiles. Taken together, our data define the differential activation states of microglia during lesion development in multiple sclerosis-affected CNS tissues and underscore the plasticity of human adult microglia in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Here, we show that the increased TSPO expression in multiple sclerosis lesions primarily represents an intermediate activation state in which cells expressed both CD40 and CD206 (Vogel et al., 2013; Peferoen et al., 2015); microglia solely expressing the pro-inflammatory marker CD40 or the anti-inflammatory marker mannose receptor CD206 were sparsely represented.”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Peferoen et al., 2015
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, microglia/macrophages in multiple sclerosis lesions adopt an intermediate phenotype, and the classical M1 (pro-inflammatory) and M2 (anti-inflammatory) phenotypes probably represent extreme states only found in vitro (Peferoen et al., 2015).”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Peferoen et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Here, we show that the increased TSPO expression in multiple sclerosis lesions primarily represents an intermediate activation state in which cells expressed both CD40 and CD206 (Vogel et al., 2013; Peferoen et al., 2015); microglia solely expressing the pro-inflammatory marker CD40 or the anti-inflammatory marker mannose receptor CD206 were sparsely represented.”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Peferoen et al., 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data
Ruijter, J. M., Ramakers, C., Hoogaars, W. M. H., Karlen, Y., Bakker, O., van den Hoff, M. J. B., & Moorman, A. F. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp045 · Cited by 3,043
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Repertoire of microglial and macrophage responses after spinal cord injury
David, S., & Kroner, A. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3053 · Cited by 1,297
Microglial priming in neurodegenerative disease
Perry, V. H., & Holmes, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.38 · Cited by 1,127
Research works printed but not linked: 1
- 10.1097/65.2.124 · DOI
Cited by
Sorted by citations
Items 101–178 of 178
de Jong, C. G. H. M., Stancic, M., Pinxterhuis, T. H., van Horssen, J., van Dam, A., Gabius, H., & Baron, W. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly081 · Cited by 21
Kaneko, K., Irie, S., Mawatari, A., Igesaka, A., Hu, D., Nakaoka, T., Hayashinaka, E., Wada, Y., Doi, H., Watanabe, Y., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05719-7 · Cited by 20
OMIP‐041: Optimized multicolor immunofluorescence panel rat microglial staining protocol
Furman, N. E. T., Prabhakara, K. S., Bedi, S. S., Cox, C. S., & Olson, S. D. (2017) · Cytometry Part A · doi:10.1002/cyto.a.23267 · Cited by 20
Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis
Aarts, S. A. B. M., Seijkens, T. T. P., Kusters, P. J. H., van Tiel, C. M., Reiche, M. E., den Toom, M., Beckers, L., van Roomen, C. P. A. A., de Winther, M. P. J., Kooij, G., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5205 · Cited by 19
Macrophage-Associated Disorders: Pathophysiology, Treatment Challenges, and Possible Solutions
Yadav, D. K., Pradhan, M., Singh, D., & Singh, M. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-84164-5_4 · Cited by 20
Deciphering the heterogeneity of myeloid cells during neuroinflammation in the single‐cell era
Borst, K., & Prinz, M. (2020) · Brain Pathology · doi:10.1111/bpa.12910 · Cited by 17
Immunopathology of the optic nerve in multiple sclerosis
Blanco, L. F., Marzin, M. C., Leistra, A., van der Valk, P., Nutma, E., & Amor, S. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac063 · Cited by 19
Self-citationMolecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease
Khan, F. Z., Mostaid, M. S., & Apu, M. N. H. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09874 · Cited by 20
Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis
Chen, J. Q. A., McNamara, N. B., Engelenburg, H. J., Jongejan, A., Wever, D. D., Hopman, K., van Rixel, E., Nijhuis, P. J. H., de Winter, F., Moerland, P. D., et al. (2025) · Brain · doi:10.1093/brain/awae414 · Cited by 17
Mendiola, A. S., Church, K. A., Cardona, S. M., Vanegas, D., Garcia, S. A., Macklin, W. B., Lira, S. A., Ransohoff, R. M., Kokovay, E., Lin, C. A., et al. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15616 · Cited by 15
Microglia subtypes in acute, subacute, and chronic multiple sclerosis
Prineas, J. W., & Lee, S. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad046 · Cited by 16
Palacio, P. L., Pleet, M. L., Reátegui, E., & Magaña, S. M. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578064 · Cited by 18
Microglia polarization by methylprednizolone acetate accelerates cuprizone induced demyelination
Noorzehi, G., Pasbakhsh, P., Borhani-Haghighi, M., Kashani, I., Madadi, S., Tahmasebi, F., Nekoonam, S., & Azizi, M. (2018) · Journal of Molecular Histology · doi:10.1007/s10735-018-9786-z · Cited by 15
Characterizing microglial gene expression in a model of secondary progressive multiple sclerosis
Vainchtein, I. D., Alsema, A. M., Dubbelaar, M. L., Grit, C., Vinet, J., van Weering, H. R. J., Al‐Izki, S., Biagini, G., Brouwer, N., Amor, S., et al. (2022) · Glia · doi:10.1002/glia.24297 · Cited by 13
Self-citationNheu, D., Ellen, O., Ye, S., Öztürk, E., Pagnin, M., Kertadjaja, S., Theotokis, P., Grigoriadis, N., McLean, C., & Petratos, S. (2022) · Cells · doi:10.3390/cells11233768 · Cited by 16
Hu, X., Fu, S., & Ai, S. (2020) · Journal of Differential Equations · doi:10.1016/j.jde.2020.05.020 · Cited by 14
van Wageningen, T. A., Antonovaité, N., Paardekam, E. J., Brevé, J. J. P., Iannuzzi, D., & van Dam, A. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02134-x · Cited by 12
Liu, Z., Zhu, Z., He, Y., Kang, Q., Li, F., Zhang, W., He, Y., Lin, Y., Huang, B., Mo, M., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.780447 · Cited by 13
Perdaens, O., & Pesch, V. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312637 · Cited by 12
Swanson, M. E. V., Mrkela, M., Turner, C. P., Curtis, M. A., Faull, R. L. M., Walker, A. K., & Scotter, E. L. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01941-0 · Cited by 14
Immune activation of the p75 neurotrophin receptor: implications in neuroinflammation
Danelon, V., Garrett-Thomson, S. C., Almo, S. C., Lee, F. S., & Hempstead, B. L. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1305574 · Cited by 10
The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?
Ellen, O., Ye, S., Nheu, D., Dass, M., Pagnin, M., Öztürk, E., Theotokis, P., Grigoriadis, N., & Petratos, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311112 · Cited by 11
Tissue-specific features of microglial innate immune responses
Timmerman, R., Burm, S. M., & Bajramovic, J. J. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104924 · Cited by 10
Benoit, R. Y., Zagrodnik, J. L., Carew, S. J., & Moore, C. S. (2024) · ImmunoHorizons · doi:10.4049/immunohorizons.2400045 · Cited by 8
Transient Receptor Potential Vanilloid 4-Dependent Microglial Function in Myelin Injury and Repair
Holloman, J. P., Dimas, S. H., Archambault, A. S., Filipello, F., Du, L., Feng, J., Zhao, Y., Bollman, B., Piccio, L. M., Steelman, A. J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317097 · Cited by 8
Palazzo, E., Luongo, L., Guida, F., de Novellis, V., Boccella, S., Cristiano, C., Marabese, I., & Maione, S. (2019) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000549 · Cited by 8
Human immunomodulatory ligand B7-1 mediates synaptic remodeling via the p75 neurotrophin receptor
Morano, N. C., Smith, R. S., Danelon, V., Schreiner, R. P., Patel, U., Herrera, N. G., Smith, C., Olson, S. M., Lærke, M. K., Celikgil, A., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157002 · Cited by 8
Non-invasive in vivo imaging of brain and retinal microglia in neurodegenerative diseases
Etebar, F., Harkin, D. G., White, A. R., & Dando, S. J. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1355557 · Cited by 7
Gargano, F., Lombardo, M. C., Rizzo, R., Sammartino, M., & Sciacca, V. (2024) · International Journal of Non-Linear Mechanics · doi:10.1016/j.ijnonlinmec.2024.104672 · Cited by 8
Human Brain In Vitro Model for Pathogen Infection-Related Neurodegeneration Study
Yan, Y., & Cho, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126522 · Cited by 7
Unresponsiveness of Experimental Canine Leishmaniosis to a New Amphotericin B Formulation
Hernández, L., Bolás-Fernández, F., Montoya, A., Checa, R., Dado, D., Gálvez, R., Serrano, D. R., Torrado, J. J., Otranto, D., Latrofa, M. S., et al. (2015) · Advances in Pharmaceutics · doi:10.1155/2015/160208 · Cited by 8
Xing, Y., Liu, B., Zhao, Y., Zhang, L., Thomé, R., Xue, H., Zhang, P., & Ma, C. (2019) · Folia Neuropathologica · doi:10.5114/fn.2019.85843 · Cited by 7
Blenkle, A., Geladaris, A., & Weber, M. S. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01647-w · Cited by 6
The potential role of dietary intervention for the treatment of neuroinflammation
Holton, K. F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85841-0.00022-5 · Cited by 6
Translational utility of experimental autoimmune encephalomyelitis: recent developments
Jagodic, M., Guerreiro‐Cacais, A. O., Lindahl, H., Flytzani, S., N’diaye, M., & Olsson, T. P. (2015) · Journal of Inflammation Research · doi:10.2147/jir.s76707 · Cited by 6
Donskow‐Łysoniewska, K., Krawczak, K., Machcińska, M., Głaczyńska, M., & Doligalska, M. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.08.004 · Cited by 6
Paul, D., & Basavan, D. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00446-0 · Cited by 5
Characteristics of TSPO expression in marmoset EAE
Falk, I., Maric, D., Leibovitch, E., Sati, P., Lefeuvre, J., Luciano, N. J., Guy, J., Ha, S.-K., Owen, D. R., Aigbirhio, F., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03343-4 · Cited by 5
Metal ions potentiate microglia responsiveness to endotoxin
Rachmawati, D., Peferoen, L. A. N., Vogel, D. Y. S., Alsalem, I. W. A., Amor, S., Bontkes, H. J., Blomberg, B. M. E. V., Scheper, R. J., & van Hoogstraten, I. M. W. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.12.013 · Cited by 5
Self-citationDermatitis in a cat associated with Spilopsyllus cuniculi.
Harvey, R. G. (1990) · PubMed · Cited by 5
Zhang, Q., Zhang, L., Zhao, N., & Yang, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1561939 · Cited by 4
Neuroprotection induced by lycopene
Ugbaja, R. N., Ugwor, E. I., James, A. S., Ugbaja, V. C., & Ezenandu, E. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00045-2 · Cited by 4
Fish and Fish Oil for the Aging Brain
Butt, C. M., & Salem, N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802844-5.00012-9 · Cited by 5
Gargiulo, S., Coda, A. R. D., Panico, M., Gramanzini, M., Moresco, R. M., Chalon, S., & Pappatà, S. (2017) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.16.02948-4 · Cited by 6
B cell-specific METTL3 depletion exacerbates experimental autoimmune encephalomyelitis
Pei, X., Wang, X., Ding, J., Yu, H., Xue, C., Xie, C., Chen, Y., Lin, X., Yang, H., & Guan, Y. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-06028-6 · Cited by 3
Parida, B. P., Misra, B. B., & Misra, A. N. (2018) · 4open · doi:10.1051/fopen/2018004 · Cited by 3
Davies, C. L., Gyoneva, S., Cotleur, A. C., Ransohoff, R. M., & Miron, V. E. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9072-6_2 · Cited by 3
Dysregulated Expression of Inflammasome and Extracellular Matrix Genes in C9orf72 -ALS/FTD Microglia
Thiry, L., Pulimood, N. S., Tang, Y. M., & Stifani, S. (2025) · ASN NEURO · doi:10.1080/17590914.2025.2542998 · Cited by 4
Yang, J., Fu, Z., Zou, Q., Li, Z., & Xing, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s535154 · Cited by 2
Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis
Stojković, L., & Živković, M. (2016) · Medicinski casopis · doi:10.5937/mckg50-12081 · Cited by 2
Franck, E., Storm, J. A., Lu, J., Obtial, M. F., & Wijenayake, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.26.615202 · Cited by 3
Innate immunity and biomarkers of multiple sclerosis relapse versus remission
Karadeniz, M., Wesselingh, R., Jayakrishnan, P. C., Sequeira, R. P., van der Walt, A., Butzkueven, H., & Monif, M. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104058 · Cited by 1
Global boundedness and stability for a chemotaxis model of Boló’s concentric sclerosis
Hu, X., & Fu, S. (2020) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2020277 · Cited by 1
Ploumakis, A., Weiner, H. L., & Patsopoulos, N. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801496-7.00016-2 · Cited by 1
Snelgrove, A. M. G., Galloway, D. A., & Moore, C. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.19012-5
Differential Reactivity of Microglia in Two Mouse Models of Multiple Sclerosis
Hartley, R. K. (2016) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/8pqb-mw19
Inflammasome-mediated activation of microglia : Tissue-specific features of innate immunity
Burm, S. M. (2016) · Utrecht University Repository (Utrecht University)
On the role of macrophages, microglia and the extracellular matrix in remyelination
Wang, P. (2018) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Sclérose en plaques : les nouvelles approches physiopathologiques
Zéphir, H. (2019) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2019.02.011
Kozloski, G. A. (2019) · Materials and Methods · doi:10.13070/mm.en.9.2758
Pathophysiology and Imaging Diagnosis of Demyelinating Disorders
Bernitsas, E. (2018) · MDPI eBooks · doi:10.3390/books978-3-03842-944-9
Kozloski, G. A. (2019) · Materials and Methods · doi:10.13070/mm.en.9.2844
Timmerman, R. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1603
Neuroinflammation-microglia and neurodegeneration
Fathy, A. M., Mostafa, D. M., Sedeq, H. T., Hassan, H. A., Abdullah, H. W., Fawzy, M. M., Abdelgilil, M. E., Ebrahim, Y. A., & El-Sayed, W. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00005-1
Dysregulated expression of inflammasome and extracellular matrix genes in C9orf72 -ALS/FTD microgliaPreprint
Pulimood, N. S., Thiry, L., Tang, Y. M., & Stifani, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.13.638162
Snelgrove, A. M. G., Galloway, D. A., & Moore, C. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00518-4
van Wageningen, T. A., Antonovaité, N., Paardekam, E. J., Brevé, J. J. P., Iannuzzi, D., & van Dam, A. (2021) · Figshare · doi:10.6084/m9.figshare.14337754
Sanson, C. (2017) · theses.fr (ABES) · doi:10.70675/205f3741zaac1z422eza6aeza2902010260f · Cited by 1
Pharmacogenomic identification of small molecules promoting oligodendrogenesis and myelin repair
Huré, J.-B. (2022) · theses.fr (ABES) · doi:10.70675/17691e80z7bacz455fzba89z49fef7be0512
Characterization of IFN-γ-mediated cellular responses in the HMC3 cell line
Franck, E., Storm, J. A., Lu, J., Obtial, M. F., & Wijenayake, S. (2026) · Biochemistry and Cell Biology · doi:10.1139/bcb-2025-0283
Abdallah, A., McCaig, P. C., Hislop, J., & Murray, F. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112878
Ghosh, D., & Kumar, A. (2026) · Neuroglia · doi:10.3390/neuroglia7040033
Evaluating the Clinical Utility of TSPO-PET in MS and the Influence of Methodological Heterogeneity
Neishaboori, A. M., Agarwal, M., Kalinsky, A., Lofaso, J. P., Rampilla, G., Kras, E. A., Nagy, S. C., Cooper, J. G., Ai, S., Zhang, C. K., et al. (2026) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200658
Metadata
- Authors
- Peferoen, L. A. N., Vogel, D. Y. S., Ummenthum, K., Breur, M., Heijnen, P. D. A. M., Gerritsen, W. H., Peferoen-Baert, R. M. B., van der Valk, P., Dijkstra, C. D., & Amor, S.
- Affiliations
- Queen Mary University of London (GB)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Amor, Sandra
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01
- Volume
- 74
- Issue
- 1
- Pages
- 48-63
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W2079198405
- Cited by
- 178
- References
- 66
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 10 · 2023: 11 · 2022: 19 · 2021: 11 · 2020: 18 · 2019: 24 · 2018: 13 · 2017: 17 · 2016: 26 · 2015: 15
- FWCI
- 14.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- microglial activation, multiple sclerosis, remyelination, macrophage polarization, microglial plasticity, CD40, CD74, CCL22, CD206, CD86, CXCL10, normal-appearing white matter, lesion progression, microglial markers
- MeSH terms
- Aged, Aged, 80 and over, Histocompatibility Antigens Class II, Brain, Cell Differentiation, Cells, Cultured, Female, Flow Cytometry, Humans, Macrophages, Male, Middle Aged, Multiple Sclerosis, RNA, Messenger, Antigens, CD, Cytokines, Microglia, Statistics, Nonparametric, Myelin Proteolipid Protein, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
